A Cross-Reacting Embryonic Antigen in the Membrane of Rat Sarcoma Cells which is Immunogenic in the Syngeneic Host by Thomson, D. M. P. & Alexander, P.
Br. J. Cancer (1973) 27, 35
A CROSS-REACTING EMBRYONIC ANTIGEN IN THE MEMBRANE OF
RAT SARCOMA CELLS WHICH IS IMMUNOGENIC IN THE SYNGENEIC
HOST
D. M. P. THOMSON* AND P. ALEXANDER
From the Chester Beatty Research Institute, Laboratories at Clifton Avenue, Belmont, Sutton,
Surrey, England
Received 28 September 1972. Accepted 17 October 1972
Summary.-An analysis of the constituents of the plasma membrane of a methyl-
cholanthrene-induced sarcoma (the MCI tumour) in a hooded rat revealed four
tumour-associated macromolecules. Two of these were antigenic in the syngeneic
host, one was unique to the MC1 tumour and could not be detected in embryo tissue
and has the properties to be expected from the well established tumour-specific
transplantation-type antigen while the other, referred to as OEA I, was present in
all rat sarcomata tested as well as in early embryos. Two other embryonic com-
ponents were detected in the sarcoma but these were not immunogenic in the rat.
The properties of these tumour-associated " antigens " in the membrane of rat
sarcomata are summarized below:
Antigen
TSTA
Specificity
Found only in MC-I
and not in
embryonic tissue
OEA I Found in many rat
sarcomata and in
early but not in late
embryos
OEA II Found in perchloric
acid soluble extract
of all rat tumours,
in embryos and in
low concentration in
adult tissue
OEA III Found in early
embryos, all rat
tumours and adult
skin
Antigenic in
syngeneic
host
Yes
Yes
No
No
Molecular
weight
Antisera used to
detect it
40-50,000 (a) Serum of
syngeneic rats
hyperimmunized
with MC-I
tumour
Unknown (b) Xenogeneic
Antiserum I
raised to aqueous
extract of MC-I
sarcoma and
absorbed by
normal tissue
40,000 Xenogeneic Antiserum
II raised to perchloric
acid extract of MC-I
and absorbed by
perchloric acid
extracted normal
adult tissue
67-70,000 Xenogeneic Antiserum
III raised to aqueous
extract of 9-11 day
embryos and absorbed
by extracts from
normal adult tissue
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CHEMICALLY-INDUCED sarcomata in
experimental animals have been shown
by transplantation tests to have in their
membranes a tumour specific transplanta-
tion antigen (TSTA) which evokes an
immunological host reaction such that
following suitable immunization proce-
dures tumour cells are rejected. TSTAs,
when assayed by graft rejection and in
vitro cytotoxicity tests, appear not to
cross-react and to be unique for each
particular chemically-induced tumour. In
addition to these antigens which are
unique to each individual tumour there
are tumour-associated macromolecules
which are common to many tumours;
frequently these are substances normally
found only in embryonic life. Against
virally induced sarcomata of the hamster
such embryonic antigens induce graft
rejection (Coggin, Ambrose and Anderson,
1971) but in other tumour systems the
presence ofembryonic antigens has usually
been identified by xenogeneic antisera and
referred to as tumour-antigens, but this is
in some respects a misnomer since they
may not be antigenic in the syngeneic
host. Stonehill and Bendich (1970) using
xenogeneic antiserum, provided evidence
for such one " antigen " present in a
wide variety of mouse tumours, embryos
and adult skin but no other adult tissue.
Baldwin, Glaves and Pimm (1971) found
that the serum from syngeneic multi-
parous rats bound to the membranes of
many rat tumours, and interpreted this as
indicating the presence of an embryonic
substance, but this did not appear to be
antigenic in the tumour bearing host.
However, hypersensitivity tests
showed that chemically induced rat
sarcomata contain in addition to the
TSTA unique to each tumour, a tumour-
specific material common to all sarcomata
tested, against which the tumour bearing
host reacts (Wang, 1968). This common
tumour antigen was shown to be of
embryonic origin (Alexander, 1971).
Recently Taranger et al. (1972) re-
ported that papillomata and carcinomata
induced in the bladder of mice and rats
contain a common antigen against which
the tumour bearing host mounts a cell-
mediated immune response. This antigen
appeared to be confined to bladder
tumours and was not found in chemically-
induced sarcomata and may therefore
differ from that reported in sarcomata by
Wang (1968) and Alexander (1971).
In the present investigation we found
that sera from rats resistant to a syn-
geneic sarcoma contained, in addition to
antibodies to the TSTA, an antibody
against a membrane component present in
unrelated rat tumours. In other words,
there appears to be in the membrane of
cells from several different tumours a
common component immunogenic to the
svngeneic host. This material is also
found in rat embryos. The onco-
embryonic antigen (OEA) detected by
syngeneic immune serum was not the only
embryonic material found in the rat
sarcoma, since xenogeneic antisera showed
in addition to this OEA, two other
embryonic materials which do not appear
to be immunogenic in the syngeneic host.
One was similar or identical to that
described by Stonehill and Bendich (1970)
and the other has some similarities to the
carcino-embryonic antigen (CEA) of
human gastro-intestinal tract tumours
(Gold and Freedman, 1965). These find-
ings gave us the opportunity to assess the
potential role of embryonic antigens and
to elucidate the relationship of embryonic
" antigens " reported by others using
xenogeneic antisera, to that detected by
the syngeneic tumour immune serum.
This study was also designed to obtain
information about the location and some
physicochemical properties of the em-
bryonic antigens and to compare these
with the TSTA.
MATERIALS AND METHODS
Rats.-Inbred male hooded rats were used
throughout and their genetic identity estab-
lished by skin grafting.
Tunmours.-A transplanted sarcoma MC-I,
originally induced by 20methylcholanthrene
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subcutaneously, was selected for study
because of its strong immunogenicitv and
non-cross reaction as judged by standard
transplantation tests. All tumours were
grown intramuscularly in a hind limb and
surgically excised when 2-3 cm in diameter.
Early generations were stored at liquid
nitrogen temperature and withdrawn at
intervals for passage in syngeneic hooded
rats and tests were carried out on tumours
from generation 5-17. Other tumours used
for comparison were spontaneous or were
induced by chemicals or irradiation.
Embryonic tissues-These were obtained
free ofmaternal tissue from syngeneic hooded
rats at two different gestational periods;
9-11 days and 15-17 days.
Preparation of tuqnour, embryo and nornal
tissue extracts
(a) Aqueous extraction.-Tumours freed of
surrounding normal and necrotic tissue were
stored at -20°C until processed. For the
preparation of antigen, tissues were thawed,
finely minced with scissors, washed in
phosphate-buffered saline, suspended in 3
volumes of distilled water and homogenized
for 3-5 miii. After centrifugation at 12.000 q
for 30 min, the supernatant was dialysed
against distilled water for 24 hours, clarified
by a further centrifugation (at 10,000 g for
20 min) and lyophilized. All operations were
performed at 4°C. Embryonic, foetal and
normal tissues were similarly stored and
extracted.
(b) Perchloric acid extraction.-1-0 mol/l
perchloric acid extraction, a technique em-
ployed by Gold and Freedman (1965) for
isolating CEA of human colon carcinomata,
was used to prepare a tumour cell surface
glycoprotein extract.
(c) Crude membrane fraction8.-Finely
minced MC-J tumour was suspended in a
0-25 mol/l sucrose buffer (2 mmol/l MgCI2,
2 mmol/l, CaCI2, 1 mmol/l NaHCO3) pH 7 6,
and homogenized with an ultra-turrax, in a
controlled manner so that the nuclei re-
mained intact (Baldwin and Glaves, 1972).
The resulting tumour homogenate was centri-
fuged (at 600 g for 12 min) to remove nuclei
and debris, and the supernatant was kept.
The pellet was resuspended in sucrose buffer
and centrifuged, and this step was repeated
three times. The pooled supernatants were
then centrifuged (at 90,000 g for 2 hours) and
the pelleted membranes were dispersed in
either phosphate buffered saline or 5 mmol/l
Tris-HCl buffer, pH 7-6.
(d) Solubilization of membrane antigens.-
(1) To crude membrane fractions obtained by
the above method 10 ml of 0 4 mol/l
L-cvsteine and papain (Sigma Chemical Co.
Ltd.) at a concentration of 1 mg/30 mg mem-
brane protein were added. Incubation was for
1 hour at 37°C and the reaction was stopped
by iodoacetic acid and NaCl was added to
bring the solution to 0-15 mol/l. Following
removal of cellular debris by centrifugation
(1-5 hours at 90,000 g) the supernatant was
concentrated with aquacide 1. An alterna-
tive method for antigen preparation was also
used in which the minced tumour tissues
were suspended in 3-5 mol/l KCI (Reisfeld,
Pellegrino & Kahan, 1971) and homogenized
with an ultra-turrax. The homogenate was
gently agitated for 18 hours at 4°C, then
centrifuged (2 hours at 90,000 g). The
solubilized membrane antigens in the super-
natant w%Nere dialysed against phosphate
buffered saline for 24 hours and the DNA
precipitate was removed by centrifugation
(30 min at 1,500 g). The supernatant was
concentrated with aquacide 1 as before.
Preparation of antisera
(a) Syngeneic antiseru,m to the MC-I
fibrosarcoma was raised bv injecting viable
MC-I cells intramuscularly into hooded rats
and surgically excising the resulting tumour.
The rats then received 6 injections over 3
months of a mechanically prepared and
(15,000 rad) irradiated MC-1 tumour cell
suspension at multiple sites, including intra-
peritoneal. Rats were bled after the sixth
injection and subsequent bleeding§ were
preceded by an additional immunization.
(b) Xenogeneic antiserum.-The regimen
consisted of 3 injections over 2 weeks (at
multiple intramuscular sites) of a given
lyophilized antigen resuspended in sterile
distilled water at 5 mg/ml and emulsified
with equal volumes of complete Freund's
adjuvant. Booster injections of 2 ml were
prepared with incomplete Freund's adjuvant
and administered subcutaneously at the
fourth week. Blood was collected 2 weeks
later and subsequent bleedings were preceded
by an additional booster of an emulsion of
incomplete Freund's adjuvant and the anti-
gen extract.
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Absorption procedures
The initial absorption of the xenogeneic
antisera was performed with normal rat
serum that had been insolubilized by cross-
linking with glutaraldehyde (Avrameas and
Ternynck, 1969). Further absorptions were
by addition of an excess of a lyophilized pool
of aqueous extracted syngeneic rat tissue,
comprising heart, lung, liver, spleen, gut,
skin, skeletal muscle and connective tissue.
Approximately 75-150 mg of lyophilized
normal tissue extracts were needed to absorb
fully 1 ml of xenogeneic antisera. The
reaction mixture was incubated for 1 hour
at RT, then 18 hours at 4°C when it was
clarified by centrifugation (20 min at 20,000g;
4VC). Intheinstance ofxenogeneic antiserum
to the MC-1 perchloric acid tumour extract,
absorptions were performed with perchloric
acid extracted normal serum (30-50 mg) and
tissues (20-30 mg).
Assay techniques
(1) Indirect membrane immunofluorescence
was performed on viable single tumour cell
suspensions obtained from finely minced
solid tumour with 0.04% trypsin and 0.04%
collagenase in the presence of a small amount
of DNAase. When xenogeneic antiserum
was tested, lymphocyte suspensions prepared
from teased normal hooded rat spleens were
used as controls. Xenogeneic antiserum was
used at dilutions 1/5 to 1/40. Syngeneic
tumour immune serum was tested at dilutions
1/4 to 1/12. The appropriate fluorescein-
conjugated antiserum to rat y-globulins or
rabbit y-globulins (Wellcome Reagents) was
used at 1 : 12 dilution. Inorderto quantitate
the results, fluorescent indices (FI) were
calculated:
% staining of cells
Fl = with specific antiserum % staining of cells with normal serum
A reaction was defined as positive when the
FI was equal to, or greater than 2-5 for both
syngeneic and xenogeneic antisera.
(2) Inhibition of membrane immunofluor-
escence.-The antigenic activityin the various
samples of lyophilized tissue extracts or their
concentrated chromatographic fractions was
detected and quantitated by their capacity to
inhibit antiserum from binding to its cell
surface antigens on viable MC-1 tumour cells.
The lyophilized antigens were added in equal
amounts by weight to the appropriately
diluted antiserum. In the instance of
antigens already in solution, the antiserum
was diluted with this. The mixtures were
incubated for 1 hour at RT, then overnight
at 4°C and clarified before use (20 min at
4,000 g; 4°C). The amount of antibody not
complexed to antigen was assayed by
membrane immunofluorescence. The pre-
sence ofspecific antigen inthe sample reduced
the fluorescent index compared with that
obtained with antisera alone or antisera
incubated with normal tissue extracts.
(3) Immunodiffusion-This was performed
in 1/O Agar (Difco) with the addition of
2.5% polyethylene glycol (6,000 MW) in
barbitol buffer (pH 8.2) (Harrington, Fenton
and Pert, 1971). The wells had an outside
diameter of5 mm, and 3 mm separation, and
these were filled and the slides incubated at
37°C for 24 hours in a moist chamber and
continued for 7 days at 4°C to observe the
development of additional precipitin lines.
The technique of ICD of Darcy (1972) was
also employed to detect soluble Ag-Ab
complexes. At the time of testing, the
lyophilized material was resuspended in a
minimum volume of distilled water. Protein
concentrations of these final tissue extracts
as determined by spectrophotometric absor-
bence at 280 nm wave length (albumin
standard) ranged from 50-60 mg/ml.
(4) Precipitation-inhibition assay.-This
technique was employed to detect antigens
present in concentrations too low to give
precipitation reactions by immunodiffusion.
The lyophilized material to be studied was
added to the antiserum and incubated
overnight at 4°C. The control unabsorbed,
and the absorbed test antisera were added to
the outside wells with the antigen standard in
the centre well. The presence of antigen in
any lyophilized tissue extract used to absorb
the test sera resulted in the retardation ofthe
movement of the precipitation reaction
towards the centre well.
(5) Chromatographicfractionation ofextracts.
-Column chromatography was carried out
in 4 cm2 x 55 cm columns packed with
Biogel A05 m, Al 5 and P-150, equilibrated
and eluted with 041 mol/l Tris, 0-2 mol/l
NaCl and 1 mmol/l EDTA buffer titrated to
pH 8 with HCI at 4°C. The columns were
calibrated with proteins of known molecular
weight and a graph of the E,/Eo against log
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MW plotted for each column. Samples
collected from one or more runs -were con-
centrated in an Amicon ultra-filtration cell
using PM-10 membranes and assayed by
immunodiffusion or inhibition of memrbrane
immunofluorescence.
RESULTS
In this investigation tumour-associated
macromolecules were studied principally
by the binding of antisera to viable cells.
The test therefore only provides data on
macromolecules present in or on the
plasma membrane of tumour cells. It is
quite possible that of the four cell surface
components to be described some may
also be found in the cytoplasm of the cell
and there may be further tumour-associ-
ated macromolecules which are found only
in the cytoplasm.
(1) Two tumour membrane components anti-
genic in the syngeneic host; the TSTA, and
an onco-embryonic antigen (OEA I).
The present investigation began with
the finding that serum of rats hyper-
immunized with syngeneic MC-I sarcoma
contained antibodies to two apparently
different antigens in the membrane of the
sarcoma cells. As Pilch and Riggins
(1966) and Baldwin and Barker (1967)
had observed, such sera reacted strongly
with the membrane of the tumour used
for immunization (Table I). Unlike the
finding of these authors, however, the
syngeneic serum against the MC-J sarcoma
also contained antibody which reacted,
albeit very weakly, with the membrane of
most of the other rat tumours studied
(Table I). On testing the MC-I tumour
immune serum, diluted 1/5, on MC-I
sarcoma cells in suspension, bright and
dense staining approaching confluence
was observed on 95-1000/% of the cells and
a Fl of 13-0 or greater was continually
observed. When the MC-I tumour im-
mune serum, diluted 1/5, was tested on
unrelated sarcoma cells a Fl of 2-5 or
greater was consistently found for most
sarcomata. At greater serum dilutions,
membrane staining was still noted occa-
sionally but at barely significant levels.
Similar results were obtained usiIng a
quantitative mixed haemadsorption test
with 5'Cr-labelled indicator cells
(Thomson, Eccles and Alexander to be
published). Even after extensive absorp-
tion of the MC-I tumour-immune serum
with normal tissue to ensure that auto-
antibodies to normal cell components
which are found in rat sera (Wreir and
Elson, 1969) were removed, the FL on
unrelated tumours was not lowered.
To study the nature of the common-
cross-reacting antigen, MC-I tumour-im-
mune serum was incubated with unrelated
MC-3 sarcoma cells or various other
tissue extracts. It was then tested on
MC-I cells and unrelated MC-3 cells to
determine whether the antibody to the
cross-reacting antigen had been specifically
absorbed (Table II). As the data shows,
the 9-11 day gestation embryonic extract
lowered the FL index, but the 15-18 day
embryonic, the normal tissue, and placen-
tal extracts did not. Also, absorption
TABLE I. Membrane Immunofluorescence with Syngeneic MC-I Tumour ImmuneSerum
Tulmoui- cell sus)pensiOn-
MC- sarcoma
MIC-3 sarcoma
1 0 different 20AMC iindtuced
primary sarcomata
Benzpyrene in(luce(1 sarcoma (HSH)
Benzpyrene in(luced sarcoma (HSN)
Benzpyrene indutced sarcoma (HSG)
Piimary benzpyrene induced sarcoma
Imferon-induced sarcoma
Fluiorescence in(dex
Serum Serum
clilute( 1/o (diluted 1/11
13-1 9-0
4-0 2-9
.3-8-45-
2-6
2-3
2-9
2-9
2-9
2-5-2* 8
1*5
1 -3
2-:3
2-4
1 *'9
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TABLE II. Syngeneic MC-i Tumour Immune Serum and Inhibition of Membrane
Immunofluorescence with Antigen
Fluorescence iin(lex
Tissue extract use(l for absorpti
None (PBS)
Embryonic Ag
Placental Ag
Foetal Ag
Normal tisstue
Cells from unrelated AIC-3 sarcoma
(5 x 107/ml)
Cells from an unrelate(d primary sai
(5 x 107/ml)
'Antiserum'diluted 1 10
2Antiserum-diluted 1: 5
with unrelated tumour cells, such as
MC-3, consistently lowered the FI for the
MC-J sarcoma cells but never by more
than 30%o. On the other hand, absorption
of MC-J tumour immune serum with
unrelated sarcoma cells such as MC-3,
abolished MC-3 membrane staining. We
shall refer to this onco-embryonic antigen
as OEA I. Absorption with embryonic
material failed to abolish the reaction
against the TSTA of the MC-J, and our
experiments provide no support for the
hypothesis that the TSTA is a substance
also present in embryos.
Not unexpectedly, the syngeneic MC-1
tumour-immune serum did not produce
the usual precipitation reaction when run
by gel diffusion against an aqueous extract
of the MC-I tumour. In an attempt to
obtain a precipitating antibody, rabbits
TABLE III.-Membrane Immunofluores-
cence with Xenogenic Antiserum-I to
Whole Aqueous Extract (Absorbed).
Target Cells
Spleen cell suspension
Tuimour cell suspensions from
MC-I sarcoma
MC-3 sarcoma
Ten different primary 20MIC
in(luced sarcomata
Two diffelent primary
benzpviene induce(l sarcomata
HSH Tranisplante(d
HSG benzpy-ene in(luced
HSN J sarcomata
*Serum absorbed with normal:
normal rat tissues anct (liltte(l 1/10.
Fluorescence
index*
AIC-I cells' MCA-3 cells2
900 4-0
6-2 1-5
8-3 3-5
8-4 3-7
8-6 3-9
7-6 1-1
7-7 1-2
were immunized with an aqueous extract
ofthe MC-I tumour followed by absorption
with normal tissue. This Xenogeneic
Antiserum I was shown by membrane
immunofluorescence to react with the
TSTA ofMC-I and the OEA I on other rat
tumours (Tables III and IV). The
Xenogeneic Antiserum I on MC-I cells
gave a Fl of 8-8 and approximately 4 0 on
unrelated tumour cells. It did not stain
normal spleen cells. As the data show in
Table IV, complete absorption of the
Xenogeneic Antiserum I was obtained only
with MC-I tumour extract. Embryonic
extract and unrelated tumour cell extracts
produced a 5000 inhibition of the Xeno-
geneic Antiserum I.
On immunodiffusion a precipitation
TABLE IV. Xenogeneic Antiserum-I to
Whole MC-I Aqueous Extract (Absorbed)
and Inhibition of Membrane Immuno-
ftuorescence with Cell Extracts
1 * 5 Tissue extract 1Used for absorption
8 - 8 None (PBS)
4- 0 Aquieous extract, of normal tissues
Aqueous extracts of tumotirs:
3-84- 9 MC-I
MC-3
,3 4-3- 7 Primary 20MlC induced sarcoma
3 -5 HSH sarcoma
4- 6 AMammary adenocarcinoma
3 * 0 Aqueous extract of embryonic
tissues
rat seruim andl
Fluorescence
index with*
MC-I
sarcoma
cells
8-8
8-5
1-7
4-5
5-8
5-0
5-2
4-4
* Serum (lilute(d 1/10.
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line was obtained against an aqueous
extract of MC-I. This, however, proved
not to be due to reaction with the TSTA
or OEA I, but was due to a2 macroglobu-
lin, a serum protein absent in normal
serum but synthesized by the liver in
response to inflammation or tumours.
The rabbit x2 macroglobulin antiserum
(kindly supplied by Dr D. A. Darcy)
which produced a precipitin line of
identity with the Xenogeneic Antiserum
I gave no membrane staining of mechani-
cally-prepared MC-J tumour cells in sus-
pension.
(2) A tumour-associated embryonic
material soluble in perchloric acid (OEA
Il)
Xenogeneic Antiserum II was pre-
pared in order to test if a CEA-like
material was present in rat sarcomata
and whether this material bore any
relationship to OEA I, antibodies against
which are present in the syngeneic MC-I
tumour-immune serum. On immuno-
diffusion, the absorbed Xenogeneic Anti-
serum II gave a single precipitin reaction
with either aqueous or perchloric acid
extracts of MC-I. A reaction of complete
identity was obtained with aqueous ex-
tracts of early and late embryos and all
solid tumours tested, whether syngeneic
or allogeneic (Fig. la). No precipitin
reaction was obtained with aqueous ex-
tracts of individual organs or pooled
normal tissues. However, if perchloric
acid extracts of individual organs such as
skin, gut or liver were prepared and
highly concentrated, they gave lines of
identity with aqueous MC-J tumour
extract. The estimated antigen content
of normal and tumour tissues differed by
approximately 50-fold. We shall refer to
this material as OEA II.
OEA II is not related to the TSTA or
to OEA I since it did not inhibit the syn-
geneic MC-I tumour-immune serum
(Table V), whiclh of course contains
FIG- 1. Double immunodiffusion precipitin reactions in 1% agar gel with 30% PEG. Absorbeod
Xenogeneic antiserum II in centre well, antigen extracts in peripheral wells.
(ai) 1. Perchloric acid MC-I sarcoma;
2. Aqueous MC-I sarcoma;
3 an(l 4. aqueous 9-11 and 15--17 day embryo, iespectively.
5 and 6. Aqueous unrelated MC-3 sarcoma an(d mammary adenocarcinoma, respectively.
(b) 1. as a 1.
2. Perchloric acid gut;
3, 4 and 5. perchloric acid tumour-bearing serum; inormal serum and pool of normal adult
organs, respectivelv;
6. Biogel P-150 concentrate(1 fractions ttubes 23-27.D. M. P'. THOMSON AND P. ALEXANDER
FI.. 2. Double immunodiffusion precipitin reactions in 1 00 agar gel wvith 30o PEG. Absorbecd
Xenogeneic antiserum III in centre -well, antigen extracts in peripheral -v ells.
1. 9-11 (lay embryo;
2. MC-I sarcoma;
.3. Renal tumour;
4. MC-3 sarcoma;
5. Normal tissue;
6. 15 17 dlay embryo.
antibodies to these two antigens. By
using Xenogeneic Antiserum II to stain
living cells it was clear that OEA II is
associated with the membrane of tumour
cells. Its association, however, appears to
be less intimate than that of the TSTA or
OEA I, since after 001% trypsinization
for 1 hour the living MC-J cells now showed
only minimal staining with Xenogeneic
Antiserum II, whereas the presence of
TSTA and OEA I could still be readily
shown with the syngeneic tumour-
immune serum.
As already indicated, the tumour-
immune serum is not absorbed by OEA II
and hence it would appear that this
substance is not antigenic to the rat.
OEA II has several of the properties of
CEA but it is a muich smaller molecule
than CEA.
(3) A further embryonic component (OEA
III) on the membrane of sarcoma cells
Stonehill and Bendich (1970) have
demonstrated that antisera raised against
aqueotus extracts of embryonic tissues
cross-reacted with extracts from mouse
tumours. Adopting a similar procedure
we obtained Xenogeneic Antiserum III
raised against aqueous extracts of 9-11
day old embryos and absorbed it with
normal adult tissues (excluding skin).
This produced a precipitin reaction with a
component which was present in aqueous
extracts of every rat tumour tested, and
gave a line of complete identity with
embryonic tissue extract (Fig. 2). This
material which will be referred to as
OEA III, did not cross-react with OEA II,
the antigen extracted from tumours with
perchloric acid. In fact, OEA III was not
perchloric acid soluble, so that perchloric
acid extracted embryos or tumours gave
Ino precipitin reaction when tested with
Xenogeneic Antiserum III. Xenogeneic
Antiserum III did not give any precipitin
lines when run against extracts from
normal tissues or 14-18 day embryos.
Using inhibition of immuno-precipitation
tests, OEA III was detected in low
concentrations in aqueous extracts of
adult skin and whole 14-18 day embryos.
OEA III is not related to OEA I
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TABLE V. Inhibition of Membrane Imrnmunoftuorescence with Onco-ernbryonic Associated
Components
Syngeneic AIC-11
ttumour immunie
serum
Substanices vused for absorptieII MIC-I cells MIC-3 cells
Noine (PBS) 9 0 4 0
OEA II 9 1 3-9
OEA III partially purifiedI 9 1 3- 9
Aqueous extract of whole 9-11 day embryos 6 2 1 * 5
1Diluted 1: 10 for MC-I cells
Dilute( 1: 5 for AIC-3 cells
2Xenogeneic antiseium-I to aqueous whole extract (lilutedI1: 10
because it did not inhibit the syngeneic
tumour-immune serum in membrane im-
munofluorescence (Table V). This finding
suggests that OEA III, like OEA II, is not
immunogenic in the rat. Xenogeneic
Antiserum III, like Xenogeneic Anti-
serum II, stained the surface of viable
tumour cells and we therefore conclude
that OEA III is at or near the surface of
the tumour cell, but unlike OEA II, it is
less readily detached by trypsinization.
(4) Comparison of the physicochemical
properties of the four tumour-associated
antigens studied
(a) Presence in membrane fractions.
The relatively crude membrane prepara-
tions of MC-I tumour when added to the
Xenogeneic Antiserum I and syngeneic
MC-I tumour-immune serum completely
abolished their capacity to stain viable
tumour cells. Similarly, addition of the
membrane preparation to Xenogeneic
Antisera II and III abolished their
capacity to give precipitin lines against
the perchloric acid extracts from tumours
and the aqueous extract from embryo
respectively. Also after absorption with
the membrane fractions both Xenogeneic
Sera II and III failed to stain living
tumour cell membranes. These studies
confirm the immunofluorescent findings
that TSTA, OEA I, II and III are all
associated with the membrane.
(b) Fractionation of aqueous extracts
from MC-I by gel chromatography. The
aqueouis MC-I ttumotur extract was frac-
tionated on a Biogel column A05 m,
A15 m and P-150, and the different
fractions were assayed for antigen content
by their capacity to inhibit staining of
MC-I tumour cells, or by immunoprecipi-
tation reaction. Xenogeneic Antiserum
II gave a precipitin line only with a
fraction corresponding to a mol. wt. of
40,000 on Biogel P-150 and it represented
the perchloric acid soluble OEA II.
Xenogeneic Antiserum III to the aqueous
embryonic extract gave an immuno-
precipitation reaction with a substance
appearing in the mol. wt. range of 65-
70,000 and is OEA III.
The syngeneic MC-I tumour-immune
serum was absorbed by material appearing
in the excluded volume on Biogel A05 m
and AO-15 m (i.e., of molecular weight
greater than 1 x 106). This high molecu-
lar weight material with TSTA and OEA I
activity probably consisted of membrane
fragments and the data are consistentwith
the interpretation that OEA II and III
are relatively easily detached from the
membrane while TSTA and OEA I
require special treatments to be released.
(c) Solubilization of antigens. Normal
transplantation antigens are released in a
soluble form from cells by digestion with
papain (Mann et al., 1969) or 3-0 mol/I
KCI (Reisfeld et al., 1971). These treat-
ments also release the tumour-associated
membrane antigens (Baldwin and Glaves,
1972; Meltzer et al., 1971) and were applied
to the MC-I tumour. Both papain and
KCI extracts prepared as described con-
taimed TSTA, OEA II and III activity as
Xenogeneic
antiserum-I2
IMC-I cells
8-8
8-0
8-0
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assayed by the capacity to prevent
membrane immunofluorescence or give
immunoprecipitation with the relevant
antisera. When a papain or KCl extract
was fractionated on Biogel A0O5 m and
P-150, OEA II and III were found in
similar fractions as obtained with aqueous
extract of MC-1. After papain digestion
or KCl extraction, the anti-TSTA activity
appeared principally in fractions with a
molecular weight of approximately 40-
50,000 (Fig. 3). This suggests that papain
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or KCI released the TSTA moiety from
the large molecular weight material of the
aqueous tumour extract.
No OEA I activity was found in the
papain or KCI extract by inhibition of
membrane immunofluorescence, but it is
possible that its presence was undetected
for quantitative reasons.
The partially purified water-soluble
TSTA isolated by exclusion chromato-
graphy as described above was immuno-
genic in the rabbit and produced
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FIG. 3. Biogel AO-5 m (upper) and P-150 (lower) chromatography of the soluble TSTA and OEA
active material obtained from papain digests of membranes from MC-I sarcoma. Protein pattern
was determined by measuring A28onm (vertical axis, left). Material eluting in volumes prior to
tube 12 and 13 was excluded from the Biogel AO-5 m and P-150 respectively. The TSTA activity
was determined by testing the contents of pooled tubes in the fluorescence inhibition assay using
MC-I tumour-immune serum. OEA activity was determined by precipitin reaction with appro-
priate xenogeneic antisera.
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xenogeneic antibody to the TSTA of the
MC-I sarcoma. This antiserum was
rendered monospecific to TSTA by selec-
tive absorption with cells from the
unrelated MC-3 sarcoma.
DISCUSSION
Neoplastic transformation by chemical
carcinogens is accompanied by a series of
modifications in the cell surface structure
and in this investigation we have charac-
terized in detail some antigenic moieties
that appear on the cancer cell surface. It
appears that chemically-induced sarco-
mata express on their cell surface three
classes of components which can be
distinguished by immunological means:
tumour-specific rejection antigens (TSTA);
onco-embryonic antigen(s); and other
onco-embryonic components not immuno-
genic in the syngeneic host.
In general, the TSTA of each
chemically-induced tumour is unique
whether detected by rejection studies or
more extensively by in vitro examination
of tumour immune reactions. In the
present study no evidence was found to
suggest that the TSTA of MC-I sarcoma
is the product ofrepressed genes.
The TSTA ofchemically-induced hepa-
tomata have been solubilized by others
(Baldwin and Glaves, 1972; Meltzer et al.,
1971), using techniques developed for
obtaining water-soluble transplantation
antigens. Here, from the MC-I sarcoma,
water-soluble TSTA was obtained by the
two methods described. In both methods,
a similar crude antigenic moiety was
found with a mol. wt., estimated by Biogel
filtration, of 40-50,000. The soluble
TSTA is biologically active as shown by
its inhibition of MC-J tumour-immune
serum in membrane immunofluorescence
and its capacity to raise xenogeneic anti-
serum. In other experiments (Thomson,
Steele and Alexander, 1973) excess soluble
TSTA and TSTA-antibody complexes
have been detected in the circulation of
tumour-bearing animals. In man,
Thomson et al. (1969) have shown by a
radioimmunoassay that colonic tumours
also release a cell surface component,
CEA, into the circulation. With the
ability to obtain water-soluble TSTA it
should be possible in the future to define
chemically the nature of the tumour-
specific rejection antigens.
The second class of components which
were found on the tumour cell surface by
membrane immunofluorescence were com-
mon to most of the tumours studied.
The syngeneic antibody to these antigens
was specifically absorbed by early
embryonic tissues whereas late embryonic
and adult tissues did not lower the anti-
body titres. The OEA I (onco-embryonic
antigen) was located on crude membrane
fragments but attempts so far to isolate it
in a soluble form have been unsuccessful.
In a somewhat analogous situation, a few
humans with cancer have a precipitating
antibody in their sera that defines a new
antigen associated with human neoplasia
(Edynack et al., 1972). This soluble
antigen, named y-feto-protein, h-as been
demonstrated to be present in extracts of
a proportion of tumours of all histological
types and it occurs in serum and some
tissues of the foetus. Like the OEA I
antigen of the rat the demonstration in
man of the y-feto-protein is dependent
entirely on the use of antibody occurring
naturally rather than xenogeneic anti-
serum. Although the data rule out the
possibility of cell surface auto-antigens
accounting for the cross-reaction, it may
still be possible that the OEA I is repre-
sented in normal adult tissues in a cryptic
form unavailable to the host immune
mechanism.
In man the immune reaction of the
host directed against surface antigens
(TSTA) of the autochthonous tumour, as
assayed by the cytotoxic action of peri-
pheral lymphocyte tumour cells in vitro,
appears to be directed principally against
antigens shared by all the tumours of the
same histological type (Hellstrom et al.,
1971). Tumours induced in experimental
animals on the other hand both by in
vitro cytotoxicity tests and by in vivo
transplantation immunity evoke a reac-
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tion directed against a TSTA which is
unique for each tumour and there appears
to be no cross-reactivity-the only excep-
tion reported so far is for bladder papil-
lomata (Taranger et al., 1972). The
present investigation may resolve this
apparent discrepancy because in the
serum of syngeneic rats, antibodies were
found which were specific to the MC-J
tumour (i.e. the MC-I TSTA) and to
another surface component (OEA I)
which is present in the membrane ofall rat
sarcomata tested, and in 9-11 day old
embryos but not in older embryos or in
the placenta. While OEA I does not
appear to evoke a degree of resistance
sufficient to be detectable by rejection of
tumour cells it clearly evokes an antibody
response and may also be responsible for
cross-reacting delayed hypersensitivity
reactions previously reported for rat
sarcomata (Wang, 1968; Alexander, 1971).
It seems quite possible that when the
TSTA is very strong it obscures the im-
mune reaction against antigens of the
OEA I type whereas in other situations,
and this may conceivably apply to man,
unique TSTA may be very weak or absent
and measurements of host response there-
fore focus on the reaction against a
cross-reacting antigen like OEA I.
The recurrence of the onco-em-
bryonic antigens in tumours can be
ascribed to alterations in the pattern of
gene regulation accompanying neoplastic
transformation. Similarly, the third class
of component expressed on the tumour
surface of rat sarcomata may be the result
of genetic derepression. In this instance,
the onco-embryonic components (OEA II
and III) are not antigenic to the host.
This probably results from their con-
tinuing presence in adult tissues since the
genes governing their synthesis are not
fully repressed. The universal appearance
of these primitive components on the cell
membrane may indicate that they have
an important role in determining the social
behaviour ofthe tumour cell. At present,
however, the biological function of the
primitive components is entirely unknown.
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